Healthcare provider profile · identity verified

Jason Michael Coben, MD

Family Practice · SIMPSONVILLE, SC · NPI 1316385099

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	400	121
Lisinopril	Lisinopril	360	108
Amlodipine Besylate	Amlodipine Besylate	325	101
Atorvastatin Calcium	Atorvastatin Calcium	314	92
Levothyroxine Sodium	Levothyroxine Sodium	257	67
Metformin Hcl	Metformin Hcl	217	71
Hydrochlorothiazide	Hydrochlorothiazide	184	58
Zolpidem Tartrate	Zolpidem Tartrate	174	28
Sertraline Hcl	Sertraline Hcl	153	46
Losartan Potassium	Losartan Potassium	145	41
Famotidine	Famotidine	137	40
Fluticasone Propionate	Fluticasone Propionate	136	54
Omeprazole	Omeprazole	134	43
Allopurinol	Allopurinol	125	32
Montelukast Sodium	Montelukast Sodium	125	36
Metoprolol Succinate	Metoprolol Succinate	122	40
Albuterol Sulfate Hfa	Albuterol Sulfate	118	39
Tamsulosin Hcl	Tamsulosin Hcl	116	40
Finasteride	Finasteride	96	29
Pantoprazole Sodium	Pantoprazole Sodium	96	32
Clonazepam	Clonazepam	94	18
Celecoxib	Celecoxib	90	34
Gabapentin	Gabapentin	85	32
Spironolactone	Spironolactone	81	26
Carvedilol	Carvedilol	74	23
Ezetimibe	Ezetimibe	74	23
Potassium Chloride	Potassium Chloride	71	22
Escitalopram Oxalate	Escitalopram Oxalate	66	19
Meloxicam	Meloxicam	64	19
Trazodone Hcl	Trazodone Hcl	64	21
Simvastatin	Simvastatin	63	18
Prednisone	Prednisone	61	48
Glipizide Er	Glipizide	58	17
Pravastatin Sodium	Pravastatin Sodium	58	16
Eliquis	Apixaban	56	16
Glipizide	Glipizide	55	17
Furosemide	Furosemide	54	24
Valsartan	Valsartan	52	18
Clopidogrel	Clopidogrel Bisulfate	49	16
Azithromycin	Azithromycin	47	42
Esomeprazole Magnesium	Esomeprazole Magnesium	46	15
Fluoxetine Hcl	Fluoxetine Hcl	42	13
Tizanidine Hcl	Tizanidine Hcl	42	14
Triamcinolone Acetonide	Triamcinolone Acetonide	42	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	13
Synthroid	Levothyroxine Sodium	40	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	12
Olmesartan Medoxomil	Olmesartan Medoxomil	38	11
Meclizine Hcl	Meclizine Hcl	36	11
Chlorthalidone	Chlorthalidone	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	12
Ondansetron Odt	Ondansetron	34	suppressed
Bupropion Xl	Bupropion Hcl	33	11
Pregabalin	Pregabalin	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	13
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	12
Mirtazapine	Mirtazapine	30	12
Benazepril Hcl	Benazepril Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	11
Metformin Hcl Er	Metformin Hcl	29	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	23
Donepezil Hcl	Donepezil Hcl	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Tradjenta	Linagliptin	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Cephalexin	Cephalexin	22	16
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Eszopiclone	Eszopiclone	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Ozempic	Semaglutide	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Ramipril	Ramipril	20	suppressed
Atenolol	Atenolol	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Cefdinir	Cefdinir	18	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Nexletol	Bempedoic Acid	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Topiramate	Topiramate	16	suppressed
Torsemide	Torsemide	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Linzess	Linaclotide	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Sucralfate	Sucralfate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	13	suppressed
Diazepam	Diazepam	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	12	suppressed
Temazepam	Temazepam	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Baclofen	Baclofen	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error